Computer Aided Drug Design in Industrial Research:
The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual c...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Berlin, Heidelberg
Springer Berlin Heidelberg
1995
|
| Schriftenreihe: | Ernst Schering Foundation Symposium Proceedings
15 |
| Schlagworte: | |
| Online-Zugang: | UBR01 Volltext |
| Zusammenfassung: | The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual challenge, like playing chess. But these reasons are no longer suf ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment |
| Beschreibung: | 1 Online-Ressource (XIII, 254 p. 21 illus) |
| ISBN: | 9783662031414 |
| DOI: | 10.1007/978-3-662-03141-4 |
Internformat
MARC
| LEADER | 00000nmm a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV046147100 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190905s1995 |||| o||u| ||||||eng d | ||
| 020 | |a 9783662031414 |9 978-3-662-03141-4 | ||
| 024 | 7 | |a 10.1007/978-3-662-03141-4 |2 doi | |
| 035 | |a (ZDB-2-SME)978-3-662-03141-4 | ||
| 035 | |a (OCoLC)1118998074 | ||
| 035 | |a (DE-599)BVBBV046147100 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 | ||
| 082 | 0 | |a 572 |2 23 | |
| 084 | |a VS 5350 |0 (DE-625)147687:253 |2 rvk | ||
| 084 | |a VX 5200 |0 (DE-625)147798:253 |2 rvk | ||
| 245 | 1 | 0 | |a Computer Aided Drug Design in Industrial Research |c edited by E. C. Herrmann, R. Franke |
| 264 | 1 | |a Berlin, Heidelberg |b Springer Berlin Heidelberg |c 1995 | |
| 300 | |a 1 Online-Ressource (XIII, 254 p. 21 illus) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Ernst Schering Foundation Symposium Proceedings |v 15 | |
| 520 | |a The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual challenge, like playing chess. But these reasons are no longer suf ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment | ||
| 650 | 4 | |a Biochemistry, general | |
| 650 | 4 | |a Pharmacology/Toxicology | |
| 650 | 4 | |a Biochemistry | |
| 650 | 4 | |a Toxicology | |
| 650 | 0 | 7 | |a CAD |0 (DE-588)4069794-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Forschung |0 (DE-588)4017894-8 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1994 |z Berlin |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Forschung |0 (DE-588)4017894-8 |D s |
| 689 | 0 | 2 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
| 689 | 0 | 3 | |a CAD |0 (DE-588)4069794-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Herrmann, E. C. |4 edt | |
| 700 | 1 | |a Franke, R. |4 edt | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662031438 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783662031421 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9783540590415 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-662-03141-4 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-2-SME | ||
| 940 | 1 | |q ZDB-2-SME_1990/2004 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031527284 | ||
| 966 | e | |u https://doi.org/10.1007/978-3-662-03141-4 |l UBR01 |p ZDB-2-SME |q ZDB-2-SME_1990/2004 |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180485963776000 |
|---|---|
| any_adam_object | |
| author2 | Herrmann, E. C. Franke, R. |
| author2_role | edt edt |
| author2_variant | e c h ec ech r f rf |
| author_facet | Herrmann, E. C. Franke, R. |
| building | Verbundindex |
| bvnumber | BV046147100 |
| classification_rvk | VS 5350 VX 5200 |
| collection | ZDB-2-SME |
| ctrlnum | (ZDB-2-SME)978-3-662-03141-4 (OCoLC)1118998074 (DE-599)BVBBV046147100 |
| dewey-full | 572 |
| dewey-hundreds | 500 - Natural sciences and mathematics |
| dewey-ones | 572 - Biochemistry |
| dewey-raw | 572 |
| dewey-search | 572 |
| dewey-sort | 3572 |
| dewey-tens | 570 - Biology |
| discipline | Chemie / Pharmazie Biologie Medizin |
| doi_str_mv | 10.1007/978-3-662-03141-4 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03420nmm a2200601zcb4500</leader><controlfield tag="001">BV046147100</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190905s1995 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783662031414</subfield><subfield code="9">978-3-662-03141-4</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-662-03141-4</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-2-SME)978-3-662-03141-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1118998074</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV046147100</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">572</subfield><subfield code="2">23</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 5350</subfield><subfield code="0">(DE-625)147687:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VX 5200</subfield><subfield code="0">(DE-625)147798:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Computer Aided Drug Design in Industrial Research</subfield><subfield code="c">edited by E. C. Herrmann, R. Franke</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin, Heidelberg</subfield><subfield code="b">Springer Berlin Heidelberg</subfield><subfield code="c">1995</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (XIII, 254 p. 21 illus)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ernst Schering Foundation Symposium Proceedings</subfield><subfield code="v">15</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual challenge, like playing chess. But these reasons are no longer suf ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry, general</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacology/Toxicology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemistry</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Toxicology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">CAD</subfield><subfield code="0">(DE-588)4069794-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1994</subfield><subfield code="z">Berlin</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Forschung</subfield><subfield code="0">(DE-588)4017894-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">CAD</subfield><subfield code="0">(DE-588)4069794-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Herrmann, E. C.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franke, R.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662031438</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783662031421</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9783540590415</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1007/978-3-662-03141-4</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-2-SME</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">ZDB-2-SME_1990/2004</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031527284</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.1007/978-3-662-03141-4</subfield><subfield code="l">UBR01</subfield><subfield code="p">ZDB-2-SME</subfield><subfield code="q">ZDB-2-SME_1990/2004</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 1994 Berlin gnd-content |
| genre_facet | Konferenzschrift 1994 Berlin |
| id | DE-604.BV046147100 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:36:31Z |
| institution | BVB |
| isbn | 9783662031414 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031527284 |
| oclc_num | 1118998074 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR |
| owner_facet | DE-355 DE-BY-UBR |
| physical | 1 Online-Ressource (XIII, 254 p. 21 illus) |
| psigel | ZDB-2-SME ZDB-2-SME_1990/2004 ZDB-2-SME ZDB-2-SME_1990/2004 |
| publishDate | 1995 |
| publishDateSearch | 1995 |
| publishDateSort | 1995 |
| publisher | Springer Berlin Heidelberg |
| record_format | marc |
| series2 | Ernst Schering Foundation Symposium Proceedings |
| spelling | Computer Aided Drug Design in Industrial Research edited by E. C. Herrmann, R. Franke Berlin, Heidelberg Springer Berlin Heidelberg 1995 1 Online-Ressource (XIII, 254 p. 21 illus) txt rdacontent c rdamedia cr rdacarrier Ernst Schering Foundation Symposium Proceedings 15 The Ernst Schering Research Foundation sponsored its 15th workshop in Berlin on October 19-21, 1994. Leading scientists from Europe and North America were invited to discuss computer-aided drug design in industrial research. Computer-aided drug design is a very exciting field and an intellec tual challenge, like playing chess. But these reasons are no longer suf ficient to justify using this method in industry, if they ever were. Fig. 1. The participants of the workshop VI Preface Therefore, when we, together with Prof. Hoyer, started to think about this workshop, our intentions quickly became clear. We were not so much interested in the very latest developments of methods or in computer-aided drug design itself - enough conferences have dealt with these topics. However, we were very interested in the usefulness and limitations of computer-aided drug design in the indu strial research process. A lot has changed in the pharmaceutical industry recently. These changes are gaining momentum, so it is the right time to think about the role of computer-aided drug design in this changing environment Biochemistry, general Pharmacology/Toxicology Biochemistry Toxicology CAD (DE-588)4069794-0 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf Forschung (DE-588)4017894-8 gnd rswk-swf Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1994 Berlin gnd-content Pharmazeutische Industrie (DE-588)4045696-1 s Forschung (DE-588)4017894-8 s Arzneimitteldesign (DE-588)4278218-1 s CAD (DE-588)4069794-0 s DE-604 Herrmann, E. C. edt Franke, R. edt Erscheint auch als Druck-Ausgabe 9783662031438 Erscheint auch als Druck-Ausgabe 9783662031421 Erscheint auch als Druck-Ausgabe 9783540590415 https://doi.org/10.1007/978-3-662-03141-4 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Computer Aided Drug Design in Industrial Research Biochemistry, general Pharmacology/Toxicology Biochemistry Toxicology CAD (DE-588)4069794-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Forschung (DE-588)4017894-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| subject_GND | (DE-588)4069794-0 (DE-588)4045696-1 (DE-588)4017894-8 (DE-588)4278218-1 (DE-588)1071861417 |
| title | Computer Aided Drug Design in Industrial Research |
| title_auth | Computer Aided Drug Design in Industrial Research |
| title_exact_search | Computer Aided Drug Design in Industrial Research |
| title_full | Computer Aided Drug Design in Industrial Research edited by E. C. Herrmann, R. Franke |
| title_fullStr | Computer Aided Drug Design in Industrial Research edited by E. C. Herrmann, R. Franke |
| title_full_unstemmed | Computer Aided Drug Design in Industrial Research edited by E. C. Herrmann, R. Franke |
| title_short | Computer Aided Drug Design in Industrial Research |
| title_sort | computer aided drug design in industrial research |
| topic | Biochemistry, general Pharmacology/Toxicology Biochemistry Toxicology CAD (DE-588)4069794-0 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd Forschung (DE-588)4017894-8 gnd Arzneimitteldesign (DE-588)4278218-1 gnd |
| topic_facet | Biochemistry, general Pharmacology/Toxicology Biochemistry Toxicology CAD Pharmazeutische Industrie Forschung Arzneimitteldesign Konferenzschrift 1994 Berlin |
| url | https://doi.org/10.1007/978-3-662-03141-4 |
| work_keys_str_mv | AT herrmannec computeraideddrugdesigninindustrialresearch AT franker computeraideddrugdesigninindustrialresearch |